Equels Thomas K bought AIM
March 4, 2025 · Form 4 insider transaction
Equels Thomas K bought 44,000 shares of AIM ImmunoTech Inc. at $0.12 per share, a transaction worth $5.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
44,000
Price
$0.12
Total value
$5.1K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 4, 2025
Filing dateMarch 5, 2025
Shares owned after1,808,029
OwnershipDirect
10b5-1 planNo
AmendedNo